Non-exercise estimated cardiorespiratory fitness and incident type 2 diabetes in adults [0.03%]
非锻炼估计心肺适能与成人2型糖尿病风险的关系
Joshua R Sparks,Xuewen Wang,Carl J Lavie et al.
Joshua R Sparks et al.
Aim(s): To examine the association between non-exercise estimated cardiorespiratory fitness (eCRF) and incident type 2 diabetes. Methods: ...
Hepatic insulin resistance affects the efficacy of metformin in patients with newly diagnosed type 2 diabetes: A Sub-Analysis of the MARCH trial [0.03%]
肝脏胰岛素抵抗影响二甲双胍在新诊断2型糖尿病患者中的疗效——MARCH研究亚组分析
Ruixiang Cui,Ying Wei,Jia Liu et al.
Ruixiang Cui et al.
Aim: Our study aimed to analyze how hepatic insulin resistance (IR) influences the efficacy of 48 weeks of metformin treatment in newly diagnosed type 2 diabetes patients. ...
Randomized Controlled Trial
Diabetes research and clinical practice. 2024 Aug:214:111788. DOI:10.1016/j.diabres.2024.111788 2024
Timing of gestational diabetes diagnosis and progression to type 2 Diabetes: A comparative analysis [0.03%]
妊娠期糖尿病诊断时间与2型糖尿病进展的关系：一项比较分析
Esther Maor-Sagie,Mordechai Hallak,Noa Haggiag et al.
Esther Maor-Sagie et al.
Aim: To evaluate and compare the risk of progressing to type 2 diabetes (T2DM) based on the timing of gestational diabetes (GDM) diagnosis during pregnancy. ...
Sex differences in the plasma glucagon responses to a high carbohydrate meal and a glucose drink in type 2 diabetes [0.03%]
2型糖尿病患者高碳水化合物餐和口服葡萄糖对血浆胰高血糖素反应的性别差异
Weikun Huang,Cong Xie,Karen L Jones et al.
Weikun Huang et al.
Elevated fasting glucagon concentrations and/or attenuated postprandial glucagon suppression are characteristics of type 2 diabetes (T2D) and contribute to hyperglycaemia. This study shows that hyperglucagonaemia is more prominent in males ...
Corrigendum to "The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: A nationwide cohort study" [Diabetes Res. Clin. Pract. 194 (2022) 110191] [0.03%]
糖尿病前期肝脂肪变性与肝脏纤维化变化对心血管结局和死亡率的影响：一项全国队列研究的更正说明
Jiyun Park,Gyuri Kim,Bong-Sung Kim et al.
Jiyun Park et al.
Prediction of the 10-year incidence of type 2 diabetes mellitus based on advanced anthropometric indices using machine learning methods in the Iranian population [0.03%]
基于机器学习方法利用高级人体测量指标预测伊朗人群2型糖尿病的10年发病率
Somayeh Ghiasi Hafezi,Maryam Saberi-Karimian,Morteza Ghasemi et al.
Somayeh Ghiasi Hafezi et al.
Background: Type 2 diabetes mellitus (T2DM) is a growing chronic disease that can lead to disability and early death. This study aimed to establish a predictive model for the 10-year incidence of T2DM based on novel anthr...
Age of type 2 diabetes onset as a risk factor for dementia: A 13-year retrospective cohort study [0.03%]
糖尿病发病年龄与痴呆之间的关系：一项13年的回顾性队列研究
Rossella Messina,Briana Mezuk,Simona Rosa et al.
Rossella Messina et al.
Aims: To examine whether age at type 2 diabetes onset is an independent predictor of dementia risk. Methods: Retrospective cohort drawn...
Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials [0.03%]
司美格鲁肽的使用与2型糖尿病患者癌症风险的关系：随机对照试验的meta分析研究
Djordje S Popovic,Dimitrios Patoulias,Lazar S Popovic et al.
Djordje S Popovic et al.
Background: Tirzepatide has recently been approved for the treatment of type 2 diabetes mellitus (T2DM), based on its impressive effects on glycemia and body weight reduction. We investigated whether tirzepatide affects t...
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison [0.03%]
特立帕肽5、10和15毫克与司美格鲁肽0.5毫克注射液治疗2型糖尿病的疗效比较：一种调整后的间接治疗对比方法
Hamza Zaheer,Muhammad Hammad Zaheer
Hamza Zaheer
Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan [0.03%]
日本2型糖尿病患者イメグリミンの実世界効果：回顧的長期観察研究
Hisayuki Katsuyama,Mariko Hakoshima,Takahiro Heshiki et al.
Hisayuki Katsuyama et al.
Objective: To examine the real-world effects of imeglimin on glycemic control and other metabolic factors in patients with type 2 diabetes (T2DM). Methods...